항생제의 Therapeutic Drug Monitoring (TDM)

키워드

참고문헌 (45)

1. Valles J, "Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival", Chest, 123, pp.1615~1624 (2003)
2. Rello J, "Improving survival for sepsis: on the cutting edge", Crit Care Med, 31, pp.2807~2808 (2003)
3. Micek ST, "Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment", Antimicrob Agents Chemother, 49, pp.1306~1311 (2005)
4. Kuti EL, "Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis", J Crit Care, 23, pp.91~100 (2008)
5. Dupont H, "Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia", Intensive Care Med, 27, pp.355~362 (2001)
6. Cosgrove SE, "Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species", Arch Intern Med, 162, pp.185~190 (2002)
7. Benet LZ, "Clinical Pharmacokinetics and Pharmacodynamics In: Encyclopedia of Pharmaceutical Technology", pp.572~590 (2006)
8. Schentag J, "Applied Pharmacokinetics & Pharmacodynamics: Principle of Therapeutic Drug Monitoring In: Aminoglycosides", pp.285~327 (2006), Lippincott Williams and Wilkins
9. Dasgupta A, "Therapeutic Drug Monitoring Data, A Concise Guide In: Therapeutic Drug Monitoring of Antimicrobial and Antiviral Agents" (2007), AACP Press
10. "The Sanford Guide to Antimicrobial Therapy 2008, In: Gilbert D, Moellering R, Eliopoulos G, Sande M, eds. 38st ed. p93, Sperryville, VA", ~ (2008)
11. "The Sanford Guide to Antimicrobial Therapy 2008, In: Gilbert D, Moellering R, Eliopoulos G, Sande M, eds. 38st ed. p88, Sperryville, VA", ~ (2008)
12. Sato M, "Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level", J Infect Chemother, 12, pp.185~189 (2006)
13. Wertheimer BZ, "Therapeutic drug monitoring in HIV treatment: a literature review", HIV Clin Trials, 7, pp.59~69 (2006)
14. Smith J, "Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations", Ther Drug Monit, 30, pp.167~172 (2008)
15. Ambrose PG, "Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore", Clin Infect Dis, 44, pp.79~86 (2007)
16. Moore RD, "The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia", J Infect Dis, 149, pp.443~448 (1984)
17. Moore RD, "Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration", J Infect Dis, 155, pp.93~99 (1987)
18. Moise PA, "Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus", Am J Health Syst Pharm, 57(2), pp.S4~S9 (2000)
19. Moise-Broder PA, "Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections", Clin Pharmacokinet, 43, pp.925~942 (2004)
20. Rybak MJ, "The pharmacokinetic and pharmacodynamic properties of vancomycin", Clin Infect Dis, 42(1), pp.S35~S39 (2006)
21. Begg EJ, "The therapeutic monitoring of antimicrobial agents", Br J Clin Pharmacol, 52(1), pp.35S~43S (2001)
22. Kim JH, "Annual Report on External Quality Assessment in Therapeutic Drug Monitoring in Korea (2005)", J Lab Med Qual Assur, 28, pp.121~134 (2006)
23. Kim JH, "Annual Report on External Quality Assessment in Therapeutic Drug Monitoring in Korea (2004)", J Lab Med Qual Assur, 27, pp.111~124 (2005)
24. Wie SH, "Therapeutic Drug Monitoring of Vancomycin", Korean J Infect Dis, 32, pp.141~147 (2000)
25. Song YG, "Therapeutic Drug Monitoring of Vancomycin in Korean Patients", Infect Chemother, 36, pp.311~318 (2004)
26. Christensen S, "Experience with once daily dosing of gentamicin: considerations regarding dosing and monitoring", Chemotherapy, 43, pp.442~450 (1997)
27. Logsdon BA, "Routine monitoring of gentamicin serum concentrations in pediatric patients with normal renal function is unnecessary", Ann Pharmacother, 31, pp.1514~1518 (1997)
28. Duffull SB, "Vancomycin toxicity. What is the evidence for dose dependency", Adverse Drug React Toxicol Rev, 13, pp.103~114 (1994)
29. Matzke GR, "Pharmacokinetics of vancomycin in patients with various degrees of renal function", Antimicrob Agents Chemother, 25, pp.433~437 (1984)
30. Tobin CM, "Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire", J Antimicrob Chemother, 50, pp.713~718 (2002)
31. Lee HJ, "The Usefulness of Therapeutic Drug Monitoring of Vancomycin", J Kor Soc Health-Syst Pharm, 23, pp.323~329 (2006)
32. Freeman CD, "Vancomycin therapeutic drug monitoring: is it necessary?", Ann Pharmacother, 27, pp.594~598 (1993)
33. Saunders NJ, "Why monitor peak vancomycin concentrations", Lancet, 344, pp.1748~1750 (1994)
34. Edwards DJ, "Routine monitoring of serum vancomycin concentrations: waiting for proof of its value", Clin Pharm, 6, pp.652~654 (1987)
35. Blouin RA, "Vancomycin pharmacokinetics in normal and morbidly obese subjects", Antimicrob Agents Chemother, 21, pp.575~580 (1982)
36. Turnidge JD, "The pharmacodynamics of beta-lactams", Clin Infect Dis, 27, pp.10~22 (1998)
37. Turnidge J, "Pharmacodynamics and dosing of aminoglycosides", Infect Dis Clin North Am, 17, pp.503~528 (2003)
38. Brunton LL, "Goodman & Gilman's Pharmacology" (2006), McGraw Hill's
39. Begg EJ, "Aminoglycosides-50 years", Br J Clin Pharmacol, 39, pp.597~603 (1995)
40. Lacy MK, "The pharmacodynamics of aminoglycosides", Clin Infect Dis, 27, pp.23~27 (1998)
41. Smyth AR, "Once-daily versus multiple- daily dosing with intravenous aminoglycosides for cystic fibrosis", Cochrane Database Syst Rev, 3, pp.CD002009~ (2006)
42. Buijk SE, "Experience with a once-daily dosing program of aminoglycosides in critically ill patients", Intensive Care Med, 28, pp.936~942 (2002)
43. Nicolau DP, "Nightingale CH:Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring", Ther Drug Monit, 18, pp.263~266 (1996)
44. Begg EJ, "A suggested approach to once-daily aminoglycoside dosing", Br J Clin Pharmacol, 39, pp.605~609 (1995)
45. Nicolau DP, "Quintiliani R:Experience with a once-daily aminoglycoside program administered to 2,184 adult patients", Antimicrob Agents Chemother, 39, pp.650~655 (1995)

관련 논문AI추천